2nd ESTRO Forum 2013 calculated 191.7cGy. The error in film measurement increases from 1.4cGy to 2.2cGy if a single film is used instead of a 5-film sample. Conclusions: Submillimeter point dose measurement with EBT2 film is shown to be very accurate. Signal extraction from such a small spatial area allows for accurate measurement in small-fields, steep dose gradients, and non-flattened beams. Purpose/Objective: An optical fibre sensor for use in radiotherapy dosimetry is presented. The sensor is based on a scintillating material coated plastic optical fibre (POF), which emits visible light when exposed to low level ionising radiation. The incident level of ionising radiation can be determined by analysing the observed emission spectra. The work presented reports on the design of the sensor and the stability of the sensor during measurement of incident x-ray energy. Initial testing of the sensor on a Linac is presented, demonstrating the suitability of such a sensor for a range of radiotherapy dosimetry applications, including the area of small field dosimetry. Materials and Methods: A 1 metre PMMA (Polymethyl Methacrylate) plastic optical fibre of 1mm diameter is prepared.The optical fibre cable end was polished, an epoxy resin and hardener mix,containing the scintillation material, was then encapsulated around the fibre cable end using an injection method and allowed to set. The radiation source used was a Siemens Artiste, with a water equivalent phantom of varying depths. The sensor was connected to a fluorescent spectrometer using a 19 meter long POF cable. The spectrometer and a computer for analysing the resultant optical signal were located at the control console. The optical fibre coated with a scintillation material fluoresces when subjected to ionising radiation. Upon scintillation, the low level light permeates the fibre optic cable end and the spectrometer placed at the distal end of the POF cable measures the received optical signal. The amount of radiation incident on the sensor is directly related to the measured intensity of the received spectrum at the preselected wavelengths. The spectrometer detects and records low level light from the sensor and detects any changes in optical intensity levels that are recorded via LabVIEW software.
Results:
The optical fibre sensor was initially tested for its response to 100MU (Monitor Units,where 1MU = 1cGy when SSD (surface to source distance) is 100cm at a depth of Dmax.) at 6MV photon energy using a 1.5cm build-up. The peak intensity of the received fluorescent signal, at 544nm, was monitored. During irradiation the sensor demonstrates a stable response and then returns to its original off state when the radiation stops. The sensor was then tested at repeated radiation doses of 100MU at 15MV to test for the stability of the optical fibre sensor at repeated exposures.
Conclusions:
The optical fibre sensor was investigated for its response to known incident radiation exposure patterns, repeatability and stability of measurement. The sensor demonstrated excellent response to a wide range of exposure conditions including different levels of ionising energy, dose rates and exposure duration. The results show that the sensor is capable of realtime, accurate and repeatable radiation dose measurements with a maximum variance of ± 2% from a Linac. Purpose/Objective: Radiochromic films such as Gafchromic EBT or EBT2 offer an excellent spatial resolution which is beneficial for dose verification in highly conformal radiation therapy such as IMRT or proton therapy. Recently, a new generation of these films, EBT3, has become available. As composition and thickness of the sensitive layer are the same as for the previous EBT2 films, a similar dosimetric performance is expected, in particular with respect to the known energy dependence of the films. The side orientation dependence, which is reported for EBT2 films, has been eliminated in EBT3 films by a symmetric layer configuration.
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Materials and Methods:
The general EBT3 film characteristics such as read-out orientation dependence and post-exposure darkening growth are evaluated and compared to EBT2 films. Film response has been investigated in clinical photon and proton beams. The energy dependence of both, EBT2 and EBT3 films, has been studied for low proton energies (<=20MeV) as predominating in the vicinity of the Bragg peak but also up to a maximum energy of 200 MeV. Results: In general, EBT3 show a comparable performance to EBT2 films, moreover, orientation dependence with respect to film side is completely eliminated in EBT3 films. Response differences of EBT2and EBT3 films are of the same order of magnitude as batch-to-batch variations observed for EBT2 films. Photon and proton exposure show similar response for both generations of EBT films. Depth dose measurements show an under-estimation of dose by up to 20 % in the Bragg peak region for both types of film. Conclusions: EBT3 and its precursor EBT2 have similar dosimetric performance and can, thus, be applied to dose verification in IMRT in the same way. Dose under-response in the Bragg peak region has to be taken into account if films are to be applied for dose verification in proton therapy. 
PO-0765
Materials and Methods:
The heterogeneous phantom was developed in the frame of IAEA Coordinated Research Project. The phantom consists of frame made with polystyrene and bone or lung equivalent inhomogeneity slabs. Special inserts allow to position TLD capsules within the polystyrene below the bone or lung material and also within the lung equivalent material. Additionally, there are inserts that allow for positioning the ionization chamber and films in the phantom. This enables comparisons of the doses calculated by TPSs for specific treatment fields in specified points with the measurements performed with various detectors. The comparisons were performed for a number of TPS (Eclipse from Varian, XiO, from CMS, Oncentra MasterPlan from Nucletron, Panther from Prowess, PrecisePlan fromElecta, Pinacle from Philips) and for a number of linear accelerators (Varian, Siemens, Elekta) in several radiotherapy departments in Poland in the framework of the Quality Assurance Audit programme in Poland. Results: Seven Polish radiotherapy centers (of 28 in total) were audited. Six different TPSs and eleven calculation algorithms were examined. Generally, most of the results obtained with TLD and ionizing chamber were within 5% tolerance. Differences between doses calculated by TPSs and measured with TLD did not exceed 4% for bone equivalent and polystyrene materials. Under the lung equivalent material, on the beam axis the differences were lower than 5% whereas inside the lung material, off the beam axis -in some cases were about 7%. Differences of doses measured with ionizing chamber under polystyrene and bone or lung equivalent materials were lower than 5%, whereas inside the lung material the difference was 5,2%.
Conclusions:
The comparison of results for calculations and the measurements allow for the detection of limitations of TPS calculation algorithms. The audits performed with the use of heterogeneous phantom seem to be an effective tool for detecting the errors in basic data configuration and the TPS performance at the audited radiotherapy departments.
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Small beam dosimetry using diamond devices F. Purpose/Objective: Recent developments of new therapy techniques using small beams, such as stereotactic radiotherapy, require new detectors to precisely determine the delivered dose. The dosimeter has to be as close as possible to tissue equivalence and exhibit a small detection volume compared to the size of the irradiation field, because of the lack of lateral electronic equilibrium. Characteristics of single crystal diamond (tissue equivalent material Z=6, high density) make it an ideal candidate to fulfill most of the small beam dosimetry requirements. Materials and Methods: We developed single crystal diamond dosimeters (SCDDo) with a small detection volume (<0.4 mm
